Verano Holdings (VRNO) Deferred Taxes (2021 - 2026)
Verano Holdings' (VRNO) quarterly Deferred Taxes came in at -$42000.0 in Q1 2026, down 103.74% year-on-year from $1.1 million in Q1 2025, and down 100.12% on a QoQ basis from $34.4 million in Q4 2025.
Verano Holdings (VRNO) Deferred Taxes (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Deferred Taxes data on file, last reported at -$42000.0 in Q1 2026.
- On a quarterly basis, Deferred Taxes fell 103.74% year-over-year to -$42000.0 in Q1 2026; TTM through Mar 2026 was $36.3 million, a 66.29% decrease from a year earlier, with the FY2025 full-year figure at $37.5 million, down 65.48% from the prior year.
- Deferred Taxes for Q1 2026 stood at -$42000.0, down from $34.4 million in the prior quarter.
- Over the last five years, Deferred Taxes for VRNO reached as high as $93.5 million in Q4 2024 and fell as low as -$355000.0 in Q2 2022.
- Historically, Deferred Taxes has averaged $15.1 million across 5 years, with a median of $3.2 million in 2022.
- Across the five-year window, Deferred Taxes surged 2235.97% in 2022 and tumbled 103.74% in 2026, its largest moves.
- Year by year, Deferred Taxes stood at $47.9 million in 2022, then sank by 93.52% to $3.1 million in 2023, then soared by 2910.66% to $93.5 million in 2024, then sank by 63.23% to $34.4 million in 2025, then tumbled by 100.12% to -$42000.0 in 2026.
- Per Business Quant data, the three most recent Deferred Taxes figures were -$42000.0 in Q1 2026, $34.4 million in Q4 2025, and $1.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | -42,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42,000.00 |
| Dec 31, 2025 | 34.38 Mn |
| Sep 30, 2025 | 1.35 Mn |
| Jun 30, 2025 | 608,000.00 |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 93.51 Mn |
| Sep 30, 2024 | 7.58 Mn |
| Jun 30, 2024 | 5.46 Mn |
| Mar 31, 2024 | 1.96 Mn |
| Mar 31, 2023 | 3.11 Mn |
| Dec 31, 2022 | 47.94 Mn |
| Sep 30, 2022 | 11.34 Mn |
| Jun 30, 2022 | -355,000.00 |
| Mar 31, 2022 | 3.21 Mn |
| Dec 31, 2021 | 32.81 Mn |
| Sep 30, 2021 | -531,000.00 |